Member Info for smudge99

Just checked and there could be another one that states energy profile but this could relate to the vit and minerals test. Using myhealthchecked energy profile blood test as the search the Google preamble throws up the following in the search response:

Thyroid profile blood test
Iron deficiency (ferritin) rapid test £9.99
Thyroid (tsh) rapid test £11.99
Worth checking yourselves as I wouldn't rely on my Google search research!

I should add the text underneath the blood test did refer to the health snap shot in time relating to the 5 or so items they test for. I believe vit d and possible iron levels were mentioned and referenced energy levels for the iron I think. It also mentioned actionable advice. Hopefully I've remembered that accurately as I never took a screen shot!

Unfortunately, it was just the one. I found it through the Google images search selecting the latest filter. It has now disappeared. I did try another search but it didn't throw any other mhc blood test images. Might be worth trying a few different searches. I recall last time we could see the images and then someone found the development website version. This one seemed to to be on the main website. Keep your eyes peeled they're bound to be on the web somewhere!

https://myhealthchecked.com/product/vitamins-minerals-profile-blood-test

Taken from the mhc QA job ad posted today. They haven't forgotten about releasing the new tests! Weirdly, the concept diagnostics name is still alive. What's that all about? saMD, software as a medical device?

Job title: Quality Assurance Associate
Location: Cardiff, Wales
Contract Type: Full-time/Permanent
Salary/Benefits: Competitive Salary + 26 days holiday including birthday + Private Health Care

Working Hours: Monday to Friday

About the Company:
MyHealthChecked Plc is a listed business (AIM: MHC) and the home of Concepta Diagnostics, an ambitious creator of at-home testing platforms and information. Under its MyHealthChecked brand, we want to make good health and wellness the most accessible it’s ever been, and our commercial plans are positively timed to coincide with consumer acceptance and desire for at-home testing services.

To position us for this growth phase, our fast-paced company has achieved over £16m of revenue in 2021 and £2.4m EBITDA, and is poised to launch further at-home tests in early 2023.

Concepta Diagnostics has ambitious plans to build innovative solutions that underpin its on-line Direct to Consumer, retail, and B2B channel growth, with evolution into SaMD.

Roly, just checked and the myhealthchecked amazon store still appears with 4 available. The glucose is out of stock but I don't recall that one was ever available on amazon. Yep, hopefully an update this week on trading and how their plans are going. Get some wind in the mhc sails. All seems to have gone flat at the moment. GLA

Andyken I've cut and pasted your original post on the mhc bb as I sometimes post there. Hopefully help spread the message in a small way.

I wouldn't normally cross post on the bb but with the last post mentioning ygen I thought it would be useful to cut and paste andyken's recent post on the ygen bb just in case pre-Christmas ygen holders miss the post. Hopefully people won't be offended. Please see the ygen bb for more details. Andyken's ygen post copied below:

Class Action

Fri 23:22

Just to provide an update. We have been speaking with a well known class action law firm about taking action against key individuals for the conduct of the company in the past year.

One of the things required to bring the case is sufficient people joining the action. A number of people on here have already provided their details but more are always welcome. This is not an action against the company and any actions taken shouldn't damage the company so there are very few reasons not to get involved.

andrewkennedy079 at Gmail

I look forward to hearing from you and please spread the word to any other investors you know.

And the nominations for the innovation category are in:

Innovation Award – Sponsored by Appleyard Lees
Brandon Medical
Synopsis
Technology in Motion
Yourgene Health
SSP Health

https://www.medilink.co.uk/award/#

The Medilink Healthcare Business Awards is a calendar highlight and has seen some of the industry’s highly commendable innovations and successes receive the recognition they deserve over the years.

https://www.med-technews.com/news/latest-medtech-news/entries-open-for-2023-medilink-north-of-england-awards/

The Innovation Award returns, sponsored by Appleyard Lees, which recognises inventive technology, design and or processes which have positively impacted the business performance.

Really?

For info a link to the updated the shareholder information page. I thought post raise there would be a few more ii involved:

https://www.yourgene-health.com/investors/securities-information/share-information

I believe the link is that mhc provide the top two pharmacies (and their own) with the flowflex tests. The relevant part of the rns is shown below:

The robust performance has been driven by the significant growth in consumer demand for the higher volume, but lower margin, COVID-19 lateral flow test kits for at-home use via the UK's top two high street pharmacy retailers.

The assumption is that these are boots and lloyds but quite why it didn't say this who knows!

https://www.lse.co.uk/rns/MHC/trading-update-guihm4c4nzmw01i.html

If the 17m tests supply quote provided earlier in this thread is accurate and relates to the flowflex tests then at £2 each it would indicate double last year's revenue but this figure seems massive. I think the lft supply started in March when the free ones were stopped. The comms have always been dreadful with this company but maybe the test quote was dropped in the media in preparation for the trading update but who knows! Happy to be corrected if people view the information differently. Fingers crossed for a bumper update!

The company distributed more than 17 million tests in the U.K. in 2022 with McCormick saying demand had been fairly consistent throughout the year.

https://fortune.com/well/2023/01/13/covid-tests-can-they-detect-new-variants-kraken-xbb-1-5/

Hopefully the pending update will provide some meaningful detail. I too don't believe the dna tests haven't been selling (hopefully this is wrong!) partly if I recall correctly that the marketing budget was going to be used for the new and existing tests. Hopefully the amazon relist and the 'take back your health' commentary is the start of a wider advertising campaign. From the last presentation it looks like 10 blood tests and 3 lft are being planned so possibly not related to the 2san ones that have appeared on lloyds website recently.

From a small amount of research I thought Thriva might be a similar to mhcs potential offering and I don't believe as large as randox. Not sure if it has a retail offering but the website traffic seems to suggest their offering is popular

https://www.similarweb.com/website/thriva.co/#overview

Hopefully mhc can replicate these visitors.

The nell acquisition does appear to have gone wrong. I noticed that a couple of the main nell players taken on by mhc don't mention their mhc employment on their linkedin profiles. Maybe just an omission though!

I'm hoping the update also offers details regarding the app/recommendations as this might be able to help differentiate between the testing companies.

Can't help but feel the blood tests are the last roll of what started out as the concepta dice. Now can they pull it off, time to roll the wheel!
GLA

https://mobile.twitter.com/tomwinnifrith

Interesting tweet. Anybody know which AIM ceo he is referring to?

And the 2022 renumerations (2021) from the annual report:
LR 394k (299k)
BH 286k (189k)
HJ 272k (187k)

Not sure if this is of use but it's a link to find the company's annual report and accounts up to may 2022 ref 5/8/22 date:

https://find-and-update.company-information.service.gov.uk/company/03971582/filing-history

Amongst others page 25 might be a pertinent page to read ref future funding risk entry.

Haven't posted on this bb for a while but noticed seven new home tests on lloyds website that are awaiting release. You may recall last year that the flowflex tests became available on the lloyds website before mhc confirmed their involvement as the go between with the retailers and the flowflex importer. Can't readily see a 2san retail website for these so wonder if mhc will have any involvement like they do with the flowflex ones or will they be a competitor for the new tests?

https://lloydspharmacy.com/collections/home-testing?page=4

Not sure what peoples thoughts are on this term so thought I'd check on Dr google if 'strategic investment' had any specific definition in the investment world.

https://www.smartcapitalmind.com/what-are-strategic-investments.htm

Assuming ygen would fall under the second definition quoted I thought the last paragraph was interesting :

When a company invests in another company as a strategic investment, it usually does so in exchange for a share of control over the company. This allows the company to protect its investment, and to shape the direction of the smaller company's business and product lines. Strategic investments may also be made with the understanding that the larger company may express a desire to take over the smaller company at some point in the future, once the small company has proved itself viable and productive.

Well I hope if there is a strategic investment the company has already taken part to gain a chunk of the company. Would seem weird to wait a few extra months.

If it happens hopefully they'll mollycoddle ygen folk into how to run a company!

And there was I thinking the ranger tech was a game changer. If it it is it sounds like it still some time away to be of benefit:

Prior to this, significant investment has been made to improve Yourgene's offering, its technology as well as its facilities and business processes. The Directors believe that the benefits from these investments will be realised over the next three years driven, primarily by leveraging Ranger® Technology to build commercial relationships within the NIPT and Oncology markets as well as utilising its improved infrastructure to support obtaining future regulatory approvals.

I wondered whether qiagen might want a look in (I appreciate it was ramped on this bb a few months back) seeing as they tried to enter the nipt market with a natera tie up in 2018 which was then terminated in March 2020 when thermofisher tried to buy qiagen. I believe this year qiagen are working with Atila BioSystems on a nipt test that is a research only use test.

https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2022/QIAGEN-Strengthens-Growing-Portfolio-of-Applications-for-Its-Digital-PCR-Platform-QIAcuity-With-New-Collaborations/default.aspx

Whatever the pending deal is I hope its a share price boosting one!